Developed compound to treat neurodegenerative diseases

Researchers from the University of Aveiro have developed a new family of compounds that may selectively inhibit enzymes linked to neurodegenerative diseases. These compounds, derived from thiazolo[5,4-d]thiazole, were initially used in solar cells and sensors but show unexpected potential in medical applications. The findings suggest a pathway for creating new agents for currently incurable diseases affecting millions globally. The innovative nature of these compounds has led to the filing of a national patent to protect their pharmaceutical composition.